Profound Medical Corporation (NASDAQ:PROF) Q1 2025 – Earnings Conference Call May 8, 2025 4:30 PM ET
Company Participants
Stephen Kilmer – Head IR
Rashed Dewan – CFO
Dr. Mathieu Burtnyk – COO
Tom Tamberrino – Chief Commercial Officer
Arun Menawat – CEO
Conference Call Participants
Ben Haynor – Lake Street Capital Markets
John McAuley – Stifel
Michael Freeman – Raymond James
Scott McAuley – Paradigm Capital
Operator
Good day, and thank you for standing by. Welcome to the Profound Medical First Quarter 2025 Financial Results Conference Call. At this time, all participants are in a listen only mode. After the speakers’ presentation, there will be a question and answer session. [Operator Instructions]. Please be advised that today’s conference is being recorded.
I would now like to hand the conference over to your first speaker today, Stephen Kilmer, Head of Investor Relations. Please go ahead.
Stephen Kilmer
Thank you. Good afternoon, everyone. Let me start by pointing out that this conference call will include forward-looking statements within the meaning of applicable securities laws in the United States and Canada. All forward-looking statements are based on ProFound’s current beliefs, assumptions and expectations and relate to, among other things, any expressed or implied statements regarding future financial performance and position and expectations regarding the efficacy of ProFound’s technologies in the treatment of prostate cancer, BPH, uterine fibroids, palliative pain treatment and osteoid osteoma. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. No forward-looking statement can be guaranteed. Listeners are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this conference call. ProFound undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise other than as required by law.
#Profound #Medical #Corporation #PROF #Earnings #Conference #Call #Transcript